Concepedia

Robel Tesfaye

RT

5

Publications

142

Citations

5

H-Index

2019

Active since

Affiliations

Inserm(Current)

Université Fédérale de Toulouse Midi-Pyrénées

Université Toulouse III - Paul Sabatier

Hôtel-Dieu de Paris

Centre Hospitalier Universitaire de Nantes

Robel Tesfaye is an author at Inserm specializing in medicine, pathology, and cancer biology.

ORCID

Top concepts

Publications per year

2019–2023

5

Publications

5

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619

Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye et al. · Cells · 2021 · 43 citations · Full text

, , +17

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth

Sarah Morice, Mathilde Mullard, Régis Brion et al. · Cancers · 2020 · 41 citations · Full text

RPL13 Variants Cause Spondyloepimetaphyseal Dysplasia with Severe Short Stature

Cédric Le Caignec, Benjamin Ory, François Lamoureux et al. · The American Journal of Human Genetics · 2019 · 30 citations · Full text

, , +7

Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis

Sarah Morice, Geoffroy Danieau, Robel Tesfaye et al. · Frontiers in Oncology · 2021 · 16 citations · Full text

POLE3 is a repressor of unintegrated HIV-1 DNA required for efficient virus integration and escape from innate immune sensing

Suzie Thenin-Houssier, Shinichi Machida, Cyprien Jahan et al. · Science Advances · 2023 · 12 citations · Full text

Rows per page

1–5 of 5